193. Prader-Willi syndrome Clinical trials / Disease details
Clinical trials : 111 / Drugs : 120 - (DrugBank : 30) / Drug target genes : 51 - Drug target pathways : 103
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03277157 (ClinicalTrials.gov) | December 8, 2017 | 7/9/2017 | B. Lactis B94 Effects of Gastrointestinal Function | The Effects of Bifidobacterium Animalis Ssp. Lactis B94 on Gastrointestinal Function in Adults With Prader-Willi Syndrome: A Randomized, Double-blind Study | Quality of Life | Dietary Supplement: B. lactis B94;Dietary Supplement: Placebo | University of Florida | Lallemand Health Solutions | Completed | 18 Years | 75 Years | All | 28 | N/A | United States |